Akers Biosciences Updates on Joint Venture in China
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
Go back to Akers Biosciences Updates on Joint Venture in China
December 1, 2015 7:03 AM EST
Akers Biosciences (Nasdaq: AKER) announces an update on the progress of its 19.9%-owned Chinese joint venture company, Hainan Savy Akers Biosciences, Ltd ("Savy Akers" or the "Joint Venture"). Savy Akers was established in October 2014 to commercialize a number of Akers Bio's rapid diagnostic screening and testing products in China (excluding PIFA Heparin/PF4 Rapid Assay products for which Chinese distribution is handled by NovoTek).
The Company is pleased to announce that Savy Akers' 10,000 square foot production facility in Haikou National Hi-Tech Industrial Zone, Hainan province, is now fully operational. This facility is an... More
December 1, 2015 7:02 AM EST
Akers Biosciences (NASDAQ: AKER) announces an update on the progress of its 19.9%-owned Chinese joint venture company, Hainan Savy Akers Biosciences, Ltd ("Savy Akers" or the "Joint Venture"). Savy Akers was established in October 2014 to commercialize a number of Akers Bio's rapid diagnostic screening and testing products in China (excluding PIFA Heparin/PF4 Rapid Assay products for which Chinese distribution is handled by NovoTek).
The Company is pleased to announce that Savy Akers' 10,000 square foot production facility in Haikou National Hi-Tech Industrial Zone, Hainan province, is now fully operational. This facility is an... More
